RxDoctor Payments Data

Scott Strum, MD

Physical Medicine & Rehabilitation · Loma Linda, CANPI 1023039609

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.1%), food and beverage and education — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 78.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $5,299 and has fallen 94.2% since, to $305 in 2025. Among physical medicine & rehabilitation clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,244in general payments, 2019–2025

Across 42 payments — averaging $172.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$6K
  • Saluda Medical Americas, Inc.$400
  • Abbott$353
  • Boston Scientific$273
  • Painteq LLC$165
  • Medtronic$97
  • plus $299 from 4 others
$17,293in research payments, 2019–2025

Across 18 payments — averaging $960.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$17K

What the payments were for

  • Speaking & faculty fees$4,28059%
  • Food & beverage$2,24131%
  • Education$72310%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,244 in reported general payments places this provider in the 90th percentile of 830 physical medicine & rehabilitation providers in California.

See all physical medicine & rehabilitation providers in California

Medicare billing

Part B allowed, 2024
$224,905
Medicare patients
486
Services billed
6,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen945$25,711
OxycontinOxycodone Hcl36$24,391
Gabapentin615$9,314
Lidocaine125$8,092
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen281$7,553
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl34$5,476
Diclofenac Sodium161$4,572
Duloxetine Hcl292$4,321
Methocarbamol243$3,923
Baclofen222$3,739
Pregabalin225$3,655
Oxycodone Hcl79$2,322
Celecoxib29$2,024
Morphine Sulfate ErMorphine Sulfate59$1,612
Morphine Sulfate35$1,506

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Loma Linda

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →